Picture Kentro Design Is Key to Your Success Berlin 650x100px

Organisation › Details

AexeRNA Therapeutics Inc.

https://aexerna.bio
Link has been incorrect on 2024-01-06

	Start	2020-10-01 established (s-off)
	Group	BioNTech (Group)
	Today	BioNTech (Group)
	Successor	BioNTech (Group)
	Industry	mRNA technology
	Industry 2	lipid nanoparticle technology (LNP technology)
	Person	Haag, Thomas A. (Linden Lake Venture Capital + AexeRNA Therapeutics 202311 CEO + Co-Founder)

	City	n. a.
		Address record changed: 2024-01-07

Basic data	Employees	n. a.


		Record changed: 2024-01-07

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for BioNTech (Group)

[1] BioNTech SE. (3/20/24). "Press Release: BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer". Mainz....
[2] BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London....
[3] BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai....
[4] BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai....
[5] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
[6] BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz....
[7] CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen....
[8] BioNTech SE. (12/18/23). "Press Release: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda". Kigali....
[9] Biotheus Inc.. (11/6/23). "Press Release: Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications". Zhuhai....
[10] Bayer, Max [Fierce Biotech]. (11/6/23). "News: BioNTech Adds Bispecific Candidate, mRNA Delivery Startup as Cancer Work Takes Center Stage"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]